» Articles » PMID: 36408534

Clinical Applications of 3D Normal and Breast Cancer Organoids: A Review of Concepts and Methods

Overview
Specialty Biology
Date 2022 Nov 21
PMID 36408534
Authors
Affiliations
Soon will be listed here.
Abstract

While mouse models and two-dimensional (2D) cell culture systems have dominated as research tools for cancer biology, three-dimensional (3D) cultures have gained traction as a new approach that retains features of biology within an system. Over time, 3D culture systems have evolved from spheroids and tumorspheres to organoids, and by doing so, they have become more complex and representative of original tissue. Such technological improvements have mostly benefited the study of heterogeneous solid tumors, like those found in breast cancer (BC), by providing an attractive avenue for scalable drug testing and biobank generation. Experimentally, organoids have been used in the BC field to dissect mechanisms related to cellular invasion and metastasis-and through co-culture methods-epithelial interactions with stromal and immune cells. In addition, organoid studies of wild-type mouse models and healthy donor samples have provided insight into the basic developmental cellular and molecular biology of the mammary gland, which may inform one's understanding of the initial stages of cancer development and progression.

Citing Articles

Stigmasterol Attenuates Triple-negative Breast Cancer Stem Cell Properties by Inhibiting JAK3.

Zhou R, Zhang Y, Xu L, Sun Y J Cancer. 2025; 16(5):1618-1630.

PMID: 39991585 PMC: 11843247. DOI: 10.7150/jca.94822.


Breast organoid suspension cultures maintain long-term estrogen receptor expression and responsiveness.

Chang K, Silvestri F, Oliphant M, Martinez-Gakidis M, Orgill D, Garber J NPJ Breast Cancer. 2024; 10(1):107.

PMID: 39702422 PMC: 11659324. DOI: 10.1038/s41523-024-00714-7.


A spheroid whole mount drug testing pipeline with machine-learning based image analysis identifies cell-type specific differences in drug efficacy on a single-cell level.

Vitacolonna M, Bruch R, Schneider R, Jabs J, Hafner M, Reischl M BMC Cancer. 2024; 24(1):1542.

PMID: 39696122 PMC: 11658419. DOI: 10.1186/s12885-024-13329-9.


Breast Cancer: Extracellular Matrix and Microbiome Interactions.

Herrera-Quintana L, Vazquez-Lorente H, Plaza-Diaz J Int J Mol Sci. 2024; 25(13).

PMID: 39000333 PMC: 11242809. DOI: 10.3390/ijms25137226.


Breast organoid suspension cultures maintain long-term estrogen receptor expression and responsiveness.

Brugge J, Chang K, Silvestri F, Olipant M, Martinez-Gakidis M, Orgill D Res Sq. 2024; .

PMID: 38947074 PMC: 11213202. DOI: 10.21203/rs.3.rs-4463390/v1.


References
1.
Hanasoge Somasundara A, Moss M, Feigman M, Chen C, Cyrill S, Ciccone M . Parity-induced changes to mammary epithelial cells control NKT cell expansion and mammary oncogenesis. Cell Rep. 2021; 37(10):110099. PMC: 8719356. DOI: 10.1016/j.celrep.2021.110099. View

2.
Buchmann B, Engelbrecht L, Fernandez P, Hutterer F, Raich M, Scheel C . Mechanical plasticity of collagen directs branch elongation in human mammary gland organoids. Nat Commun. 2021; 12(1):2759. PMC: 8115695. DOI: 10.1038/s41467-021-22988-2. View

3.
Padmanaban V, Grasset E, Neumann N, Fraser A, Henriet E, Matsui W . Organotypic culture assays for murine and human primary and metastatic-site tumors. Nat Protoc. 2020; 15(8):2413-2442. PMC: 8202162. DOI: 10.1038/s41596-020-0335-3. View

4.
Corsa C, Brenot A, Grither W, Van Hove S, Loza A, Zhang K . The Action of Discoidin Domain Receptor 2 in Basal Tumor Cells and Stromal Cancer-Associated Fibroblasts Is Critical for Breast Cancer Metastasis. Cell Rep. 2016; 15(11):2510-23. PMC: 4909540. DOI: 10.1016/j.celrep.2016.05.033. View

5.
Schutgens F, Clevers H . Human Organoids: Tools for Understanding Biology and Treating Diseases. Annu Rev Pathol. 2019; 15:211-234. DOI: 10.1146/annurev-pathmechdis-012419-032611. View